Outset Medical ROE 2019-2025 | OM
Current and historical return on equity (ROE) values for Outset Medical (OM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Outset Medical ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.09B | $0.14B | -72.06% |
| 2025-06-30 | $-0.10B | $0.16B | -99.00% |
| 2025-03-31 | $-0.11B | $0.17B | -145.22% |
| 2024-12-31 | $-0.13B | $0.03B | -216.03% |
| 2024-09-30 | $-0.14B | $0.05B | -169.37% |
| 2024-06-30 | $-0.16B | $0.07B | -145.54% |
| 2024-03-31 | $-0.17B | $0.09B | -122.69% |
| 2023-12-31 | $-0.17B | $0.12B | -102.67% |
| 2023-09-30 | $-0.18B | $0.15B | -87.83% |
| 2023-06-30 | $-0.17B | $0.18B | -73.59% |
| 2023-03-31 | $-0.17B | $0.22B | -64.70% |
| 2022-12-31 | $-0.16B | $0.25B | -55.25% |
| 2022-09-30 | $-0.16B | $0.28B | -49.85% |
| 2022-06-30 | $-0.15B | $0.31B | -42.25% |
| 2022-03-31 | $-0.14B | $0.35B | -35.38% |
| 2021-12-31 | $-0.13B | $0.37B | -34.43% |
| 2021-09-30 | $-0.10B | $0.41B | -28.17% |
| 2021-06-30 | $-0.12B | $0.43B | -32.65% |
| 2021-03-31 | $-0.11B | $0.31B | -45.66% |
| 2020-12-31 | $-0.08B | $0.33B | -46.85% |
| 2020-06-30 | $-0.04B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.082B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.189B | 34.91 |
| Tempus AI (TEM) | United States | $9.769B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.240B | 42.63 |
| Doximity (DOCS) | United States | $5.221B | 22.18 |
| IRhythm Holdings (IRTC) | United States | $4.719B | 0.00 |
| Privia Health (PRVA) | United States | $2.705B | 169.15 |
| Hinge Health (HNGE) | United States | $2.454B | 0.00 |
| Heartflow (HTFL) | United States | $2.362B | 0.00 |
| 10x Genomics (TXG) | United States | $2.355B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.909B | 31.59 |
| Omnicell (OMCL) | United States | $1.664B | 46.34 |
| Azenta (AZTA) | United States | $1.321B | 53.19 |
| Enovis (ENOV) | United States | $1.292B | 6.78 |
| Clover Health Investments (CLOV) | United States | $1.101B | 0.00 |
| Schrodinger (SDGR) | United States | $0.994B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.854B | 0.00 |
| Phreesia (PHR) | United States | $0.736B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.725B | 0.00 |
| Talkspace (TALK) | United States | $0.643B | 129.33 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Claritev (CTEV) | United States | $0.428B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| Evolent Health (EVH) | United States | $0.318B | 0.00 |
| Carlsmed (CARL) | United States | $0.310B | 0.00 |
| TruBridge (TBRG) | United States | $0.304B | 13.97 |
| Senseonics Holdings (SENS) | United States | $0.304B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.232B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.228B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.210B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 5.70 |
| American Well (AMWL) | United States | $0.073B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| HeartBeam (BEAT) | United States | $0.049B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.016B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |